The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects
Open accessAbstract
Background and aims Abdominal fat accumulation (visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG).Methods In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 +/- 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-(3)H-glucose) and GNG ((2)H(2)O) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (LF) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging.Results LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% +/- 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 micromol/min/kg(ffm); P = .02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 micromol/min/kg(ffm); P = .02). Basal hepatic IR index (EGP x fasting plasma insulin) was increased in T2DM (NGT, 816 +/- 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P = .007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05).Conclusions Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Except for a recent study of Gastaldelli et al, 17 who found no difference in insulin clearance between lean normal subjects and lean or obese type 2 diabetic patients, there are no studies in which carefully matched groups of type 2 diabetic patients and nondiabetic subjects would have been compared with respect to liver fat, hepatic insulin sensitivity, and insulin clearance.”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
In the citing paper
“In small groups of diabetic patients, insulin clearance has reported to be normal, 16 -18 decreased, 19,20 or even increased.21”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Research works printed but not linked: 1
- Matsuda, 1997, Relationship between insulin sensitivity in adipose tissue, liver, muscle and components of the insulin resistance syndrome, Diabetes, 46, 68A
Cited by
Sorted by citations
Items 501–600 of 629
Reed, R. M., Whyte, M., & Goff, L. M. (2023) · Proceedings of The Nutrition Society · doi:10.1017/s0029665123004895 · Cited by 2
Xiao, X.-P., Dai, Y., Zhang, Y., Yang, M., Xie, J. W., Chen, G., & Yang, Z. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i7.1215 · Cited by 2
Visceral Fat Accumulation and Glucose Metabolism: Significance of Mesenteric Fat Mass
Nishizawa, H., Nagao, H., & Shimomura, I. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf012 · Cited by 2
Wanders, L., Gijbels, A., Hul, G. B. J., Feskens, E. J. M., Afman, L. A., Blaak, E. E., Hopman, M. T. E., Goossens, G. H., & Thijssen, D. H. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16261 · Cited by 2
Visiting MASLD through the lens of sex, immunity, and microbial interactions
Puhan, S., Rekha, S. S., Sahu, K., Mohanty, T., De, A. J., Das, A., & Aich, P. (2025) · Discover Medicine · doi:10.1007/s44337-025-00489-1 · Cited by 2
Mandal, Š., Čaušević, A., Malenica, M., Hadzidedic, S., Prnjavorac, B., & Semiz, S. (2012) · Journal of Health Sciences · doi:10.17532/jhsci.2012.37 · Cited by 2
Diabète, facteur d’aggravation des hépatopathies
Pais, R. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30164-5 · Cited by 2
Nonalcoholic Fatty Liver Disease
Hernández, M. A. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84196 · Cited by 2
Association of insulin resistance and non-alcoholic fatty liver disease
Mishina, E. Е., Mayorov, A. Y., Bogomolov, P., Liusina, E. O., & Bueverov, A. O. (2021) · Diabetes Mellitus · doi:10.14341/dm12234 · Cited by 2
Chen, H.-J., Ko, C., Xu, J.-H., Huang, Y.-C., Wu, J. S., & Shen, S. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9967910 · Cited by 2
Application of Transmission Electron Microscopy to Detect Changes in Pancreas Physiology
Klemen, M. S., Dolenšek, J., Valladolid‐Acebes, I., Stožer, A., & Lipovšek, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104807 · Cited by 2
Bilagi, A., Kurian, J., & Bilagi, S. (2022) · Yoga Mimamsa · doi:10.4103/ym.ym_108_22 · Cited by 2
The Liver in Metabolic Syndrome
D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 2
The Effects of Thyroid Dysfunctions on Insulin Resistance in Patients with Hepatosteatosis
Keşkek, Ş. Ö., Kırım, S., Kaya, R., & Canataroğlu, A. (2014) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/37335 · Cited by 2
Cafestol: a multi-faced compound kinetics and metabolic effects of cafestol in mice
van Cruchten, S. T. J. (2010) · doi:10.18174/135163 · Cited by 2
Lan‐Pidhainy, X. (2012) · TSpace (University of Toronto) · Cited by 2
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
Abdul, M. M. S. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81575 · Cited by 2
Optimizing measures of insulin-regulated lipolysis in humans
Song, Y., Lytle, K. A., & Jensen, M. D. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00078.2025 · Cited by 1
Anyiam, O., & IDRIS, I. R. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2527791 · Cited by 1
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes
Pezzica, S., Pratesi, F., Sabatini, S., Carli, F., Mengozzi, A., Solini, A., & Gastaldelli, A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03018-7 · Cited by 1
Metabolic Liver Disease Beyond the Liver
Gastaldelli, A., Tacke, F., & Holleboom, A. G. (2026) · Clinics in Liver Disease · doi:10.1016/j.cld.2025.12.003 · Cited by 1
The mechanisms underlying COVID-19 induced insulin resistance: a narrative review
Zhu, B., Qu, S., Li, J., Deng, W., Shen, W., & Chen, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1781679 · Cited by 1
Tauriainen, M.-M., Lankinen, M. A., Hakumäki, J. M., Lahtinen, O., Husso, M., Ågren, J. J., Laakso, M., & Schwab, U. (2026) · European Journal of Nutrition · doi:10.1007/s00394-026-04031-6 · Cited by 2
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 1
The effect of 10- versus 30-minutes of acute aerobic exercise on insulin and glucose in obese adults
Mishler, A. E. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Estimer la sensibilité à l’insuline : trop d’outils tuent-ils l’outil ?
Disse, E., Elisha, B., Fellahi, S., RABASA-LHORET, R. P. R., Laville, M., & Bastard, J. (2013) · Obésité · doi:10.1007/s11690-013-0367-8 · Cited by 1
Which increases depressive symptoms in obese patients; hypertension or diabetes?
Keşkek, Ş. Ö., Haydardedeoğlu, F. E., Kırım, S., Angay, S., Ortoğlu, G., Taşdemir, M. S., Karaca, A., Toledano, Y., & Saler, T. (2013) · QScience Connect · doi:10.5339/connect.2013.9 · Cited by 1
Plourde, G. (2013) · Clinical Nursing Studies · doi:10.5430/cns.v1n2p38 · Cited by 1
Diabetes and Health Care: An Overview
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-6 · Cited by 2
Stepanov, Y. M., Nedzvetskaya, N. V., Yagmur, V. B., & Konenko, I. S. (2018) · Regulatory Mechanisms in Biosystems · doi:10.15421/021815 · Cited by 1
Shivaprasad, C., Gautham, K., Palani, P., Gupta, S., & Shah, K. (2020) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2020.05.038 · Cited by 1
Nisa, H., & Fatihah, I. Z. (2020) · Buletin Penelitian Sistem Kesehatan · doi:10.22435/hsr.v23i4.3604 · Cited by 1
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-2 · Cited by 1
From cause to consequence: Insights into incident diabetes mellitus after hepatic steatosis
Aggarwal, M., & Lindenmeyer, C. C. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000005 · Cited by 1
Jouenne, A., Hamici, K., Varlet, I., Sourdon, J., Daudé, P., Lan, C., Kober, F., Landrier, J., Bernard, M., & Desrois, M. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.09.089 · Cited by 2
Butt, M. I., Puri, G., Berkman, K., Ryder, S. J., Knowles, J., Shahzad, M. A., Malik, M. A., Shalev, N., & Sexton, J. (2024) · Journal of Endocrinology and Metabolism · doi:10.14740/jem937 · Cited by 1
Guo, C. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2vw2m · Cited by 1
Álvarez, A. Á., Falcón, M., Suárez, R. M. G., Amador, P., Calzado, M. C. A., Alonso, E. D., Puertas, A. C., Leyva, S. S., & Acosta, J. R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
High prevalence of dyslipidemia irrespective of obesity in the cape coast metropolis of Ghana
Acquah, S., Eghan, B., & Boampong, J. N. (2017) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/ijmbs.ijmbs_4_17 · Cited by 1
Фейса, С. В., Ростока-Резнікова, М. В., Tovt-Korshynska, M. I., & Сіксай, Л. Т. (2018) · Regulatory Mechanisms in Biosystems · doi:10.15421/021857 · Cited by 1
Yun, M.-J., & Kim, Y. M. (2018) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2018.12.28.6.404 · Cited by 1
Carbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Fernando Carrasco, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_21 · Cited by 1
Brockman, D. A. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Bonora, E., Brangani, C., & Pichiri, I. (2008) · Giornale italiano di cardiologia · doi:10.1714/669.7812 · Cited by 1
Hong, L. (2015) · Mspace (University of Manitoba) · Cited by 1
Adipose Triglyceride Lipase Mediated Regulation Of Sirtuin1 And Lipophagy
Sathyanarayan, A. (2016) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Hodson, K. K. (2019) · Cited by 1
Schrijnders, D. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.103517830 · Cited by 1
Yoshinaga, M. Y., Faria, F. G., Chaves‐Filho, A. B., Miyamoto, S., Pithon‐Curi, T. C., Bueno, G. C., Silva, B. F., Peres, S. B., & de Moraes, S. M. F. (2025) · medRxiv · doi:10.1101/2025.06.02.25328634 · Cited by 1
Physiological aspects of weight loss in obesity
Patel, K. (2011) · Nottingham ePrints (University of Nottingham)
Pereira, R. Z. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2009.tde-09022010-102039
Nutritional modulation of hepatic lipid metabolism in health and disease
Johnston, R. D. (2012) · Nottingham ePrints (University of Nottingham)
Yakubovich, N. (2012) · MacSphere (McMaster University) · doi:10.71548/20534
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Työväentutkimus Vuosikirja
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Omagari, K., Yoshikawa, C., Inoue, S.-I., Tanaka, Y., Murayama, T., Ichimura‐Shimizu, M., Miyata, A., Mori, S., Kamogawa, M., Hirao, E., et al. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.11343/amn.59.47
Makwana, K., Kalasava, K., & Ghori, V. (2013) · International Journal of Diabetes Research · doi:10.5923/j.diabetes.20120105.03
On the importance of fat cell size, location and signaling in insulin resistance
Franck, N. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Pretorius, J. (2012) · SUNScholar (Stellenbosch University)
Lovicu, M. (2013) · UnissResearch (Università degli Studi di Sassari)
Clinical Aspects of Fatty Liver Disease at a Tertiary Medical Center in Bogotá from 2009 to 2013
Ortíz, J. E. P., Pardo, S. S., Díaz, L. R., & Pacheco, S. H. (2014) · Revista Colombiana de Gastroenterología
The role of fermentable carbohydrates on appetite regulation in humans
Daud, M. (2012) · Spiral (Imperial College London) · doi:10.25560/14767
The Effect of Hypothyroidism on Glucose Tolerance in Dogs
Hofer‐Inteeworn, N. (2008) · VTechWorks (Virginia Tech)
Pedersen, B. K., Krogh‐Madsen, R., Thomsen, C. E., Knudsen, S. H., Hansen, L. S., Pedersen, M., Laye, M. J., Kirwan, J. P., Solomon, T. P. J., Malin, S. K., et al. (2015)
Taylor, R. (2013)
Castel, H., & Mathurin, P. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)50624-9
Tao, Y. (2009) · Jyväskylä University Digital Archive (University of Jyväskylä)
Ortíz, J. E. P., Pardo, S. S., Díaz, L. R., & Pacheco, S. H. (2014)
Kara, M., Erdal, M., Hastanesi, E. A., Asker, E., Aile, H., & Kelimeler, A. (2014)
Mechanism and functional consequence of MRP2 mislocalization in nonalcoholic steatohepatitis
Dzierlenga, A. L. (2016) · UA Campus Repository (The University of Arizona)
Metabolic and Endocrine Responses to Overeating.
Cornford, A. S. (2012) · Deep Blue (University of Michigan)
Krogh‐Madsen, R., Thomsen, C. E., Solomon, T. P. J., Klarlund, B., Knudsen, S. H., Hansen, L. S., Pedersen, M., & Dejgaard, T. F. (2012)
Välimäki, S. (2017) · Jyväskylä University Digital Archive (University of Jyväskylä)
Endocrine regulation of lipid mobilization in human obesity
Verboven (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170703kv
Furukawa, Y., Kawamori, R., Watada, H., Tamura, Y., Takeno, K., Funayama, T., Suzuki, R., Kaga, H., Watanabe, T., Someya, Y., et al. (2016) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.62.s149
Kotronen, A., Juurinen, L., Tiikkainen, M., & Vehkavaara, S. (2008)
Exercise, Protein and Vitamin D for Type 2 Diabetes Mellitus
Miller, E. G. (2017) · Figshare
NOVEL THERAPEUTIC USE OF INSULIN AND VITAMIN E IN (NAFLD) USING FATTY LIVER INDUCED RATS.
Badawy, I., Mohsen, M., Ahmed, A., Mahmoud, S., Saeed, A., Atef, A., Rabea, A., Mauric, M., & Zlat, B. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/7113
A34 EFFECT OF AUTOPHAGY INDUCTION VIA TRPML1 ACTIVATION ON HEPATIC STEATOSIS
Tersigni, C., Capurro, M., MacParland, S. A., Selzner-Malekkiani, N., & Jones, N. L. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwz006.033
Ugle, S. S., & Bikkad, M. D. (2017) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol02-i11/05
Guo, H. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/24s6-mr73
La gestione della pandemia di NAFLD: il ruolo del diabetologo
Ilaria Barchetta, F. A. C. (2021) · il Diabete · doi:10.30682/ildia2102d
Walker, M., Yu, X., & Gastaldelli, A. (2022) · doi:10.1093/med/9780198870197.003.0248
Oliveira, E. M. T. D., Leite, J. M., Ribeiro, T. M. A., & Cruz, J. F. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n4-059
Overall, abdominal, and visceral obesity in men and women: an introduction
de Mutsert, R., & Després, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822186-0.00017-1
Associations between Metabolic Phenotypes and Diabetes Risk: A Systematic Review and Meta-AnalysisPreprint
Vera-Ponce, V. J., Loayza-Castro, J. A., Zuzunaga-Montoya, F. E., Torres-Malca, J. R., García-Lara, R. A., Paucar, C. R. I., Orihuela-Manrique, E. J., Valladares-Garrido, M. J., & Cruz-Vargas, J. A. D. L. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4475216
Carbohydrate, Protein, and Fat Metabolism in Obesity
Galgani, J. E., Cortés, V., & Fernando Carrasco, N. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_21-2
Sabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4563031
Didyk, O. K., Chernyavskyi, V. V., & Shypulin, V. P. (2023) · GASTROENTEROLOGY · doi:10.22141/2308-2097.57.3.2023.554
Silva, A. K. F. N. D., Bispo, E. M. M., Muniz, G. D. S., do Nascimento, E., de Araújo, F. W. C., da Silva, L. A. R., & Melo, N. C. D. O. (2024) · OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA · doi:10.55905/oelv22n1-182
Insulinsekretion und Insulinclearance in verschiedenen Diabetessubtypen
Zaharia, O. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01206-9
Andrade, L. J. D. O., de Oliveira, G. C. M., & de Oliveira, L. M. (2024) · Research Square · doi:10.21203/rs.3.rs-4739938/v1
Gong, J., Xu, W., Chen, Y., Chen, S., Yan-yan, W., Chen, Y., Li, Y., He, Y., Yu, H., & Xie, L. Y. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400386
Histopathological Changes in Diabetic Pancreas
Rağbetli̇, M. Ç., & Kaya, A. (2023) · doi:10.69860/nobel.9786053359104.3
Phase Angle Is Related with Visceral Obesity in Young Adults
Mandryk, I., Bonior, J., & Koszarska, M. (2025) · Obesities · doi:10.3390/obesities5030061 · Cited by 1
Metadata
- Authors
- Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- University of Pisa (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 133
- Issue
- 2
- Pages
- 496-506
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2136226749
- Cited by
- 629
- References
- 43
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 40 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 47 · 2016: 34 · 2015: 26 · 2014: 39 · 2013: 37 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hepatic insulin resistance, visceral fat, liver fat, abdominal fat accumulation, type 2 diabetes, obesity, hepatic glucose production, gluconeogenesis, hepatic steatosis, hyperinsulinemic-euglycemic clamp, subcutaneous adipose tissue, hepatic lipid accumulation, hepatic lipogenesis, hepatic lipolysis
- MeSH terms
- Adult, Aging, Blood Glucose, Diabetes Mellitus, Type 2, Female, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Glucose Clamp Technique, Body Mass Index, Abdominal Fat, Glycogenolysis, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review